XML 44 R32.htm IDEA: XBRL DOCUMENT v3.4.0.3

SEGMENT INFORMATION, Revenue by Product Lines (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Revenue by product line [Abstract]
Revenue	$ 471,831	$ 543,332
Nu Skin [Member]
Revenue by product line [Abstract]
Revenue	289,989	342,766
Pharmanex [Member]
Revenue by product line [Abstract]
Revenue	180,714	199,272
Other [Member]
Revenue by product line [Abstract]
Revenue	$ 1,128	$ 1,294

X

- Definition

Aggregate revenue during the period from sale of goods in the normal course of business, before deducting returns, allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(a))
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name:	us-gaap_SalesRevenueGoodsGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationRevenueAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_ProductOrServiceAxis=nus_NuSkinMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ProductOrServiceAxis=nus_PharmanexMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ProductOrServiceAxis=nus_OtherProductLinesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: